CNS-Focused Rapport Therapeutics Preps IPO to Back Phase 2-Ready Epilepsy Drug
Rapport Therapeutics, a young biotech company with technology from the labs of Johnson & Johnson, is now preparing to enter ...
Thursday, April 24, 2025
Tag: CNSFocused
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.